Transferrin-conjugated
polymersomes, transferrin–biotin/avidin/biotin–Pluronic
F127–poly(lactic acid) (Tf-F127-PLA), were successfully prepared
through a biotin–avidin bridging technique to study their ability
to inhibit multidrug resistance of cancer cells. Hydrophilic doxorubicin
(DOX) was selected as the model drug to be loaded into Tf-F127-PLA
polymersomes. DOX loaded in Tf-F127-PLA polymersomes was released
fast initially, followed by a slow release. The effect of the transferrin
ligand density of Tf-F127-PLA/DOX polymersomes on their targeting
properties was studied by both cytotoxicity and cellular uptake assays
against A549 lung cancer cells. It was shown that Tf-F127-PLA/DOX
polymersomes had better targeting ability than nontargeted drug-loaded
polymersomes. Furthermore, Tf-F127-PLA/DOX polymersomes with 2% Tf
molar content have more effective antitumor activity and a higher
cellular uptake than those with 4 and 5% Tf molar content. 2% Tf-F127-PLA/DOX
polymersomes also exhibited better anticancer ability in multidrug
resistant cancer cells A549/ADR than nontargeted PLA-F127-PLA/DOX
polymersomes. It was further proved that the endocytosis of polymersomes
by A549/ADR cells was an energy-dependent endocytosis process, which
was related to clathrin, macrocytosis, and caveolin. Also, the endocytosis
of Tf-F127-PLA/DOX polymersomes was proven to be mediated by the transferrin
receptor.